Aortic Stenosis
Conditions
Keywords
TAVR, Balloon prediltation, success of crossing the valve, direct implanation
Brief summary
The procedure is performed via transfemoral or transcaprotid access; Patients were confirmed to be eligible for TAVR by a multidisciplinary heart team including at least an interventional cardiologist, a cardiothoracic surgeon and an anesthetist. All TAVR implantation procedures were performed with the Edwards SAPIEN 3 THV or the MEDTRONIC CoreValve EVOLUT . For all patients, both vascular access and aortic valve were evaluated before the procedure by multislice computerized tomographic angiography (MSCT) of the entire aorta using vascular windows settings. The prosthesis and the vascular access were left to the discretion of the operating team. Transfemoral access was the first choice when possible. All TAVR procedures were performed in the same hybrid room (in Montpellier University Hospital), Most TAVR were performed under sedation or general anesthesia using mild low profile 14-16 French delivery systems and using percutaneous or surgical vascular access.
Interventions
PROCEDURETranscatheter aortic valve implantation required for symptomatic aortic stenosis
The procedure is performed via transfemoral or transcarotid access; Patients were confirmed to be eligible for TAVR by a multidisciplinary heart team including at least an interventional cardiologist, a cardiothoracic surgeon and an anesthetist. All TAVR implantation procedures were performed with the Edwards SAPIEN 3 THV or the MEDTRONIC CoreValve EVOLUT . For all patients, both vascular access and aortic valve were evaluated before the procedure by multislice computerized tomographic angiography (MSCT) of the entire aorta using vascular windows settings. The prosthesis and the vascular access were left to the discretion of the operating team. Transfemoral access was the first choice when possible. All TAVR procedures were performed in the same hybrid room (in Montpellier University Hospital), Most TAVR were performed under sedation or general anesthesia using mild low profile 14-16 French delivery systems and using percutaneous or surgical vascular access.
Sponsors
University Hospital, Montpellier
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
\- patients undergoing TAVR via transfemoral or rascoarotid access
Exclusion criteria
\- others access (subclavian, apical, transaortic)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| success of the direct implantation | 1 day | success of the direct implantation defined as failure of crossing with the THV after 3 attemps and absence of complication related to the direct crossing |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Indidence of post dilatation | 1 day | Indidence of post dilatation |
| Underexpansion of the Edwards SAPIEN 3 THV | 1 day | Underexpansion of the Edwards SAPIEN 3 THV |
| risks factors of failure of crossing | 1 day | risks factors of failure of crossing : femoral vs carotid access, type of THV , vascular tortuosities, biscuipid valve, calcification, tight stenosis, horizontal aorta, small annulus |
Countries
France
Outcome results
None listed